The REAlease® CD279 MicroBead Kit was developed for rapid positive selection of CD279+ cells from PBMCs. The purified target cells are bead-free, practical for consecutive magnetic isolations, and can be label-free so that epitopes are available for any downstream application.
The REAlease® CD279 MicroBead Kit was developed for rapid positive selection of CD279+ cells from PBMCs. The purified target cells are bead-free, practical for consecutive magnetic isolations, and can be label-free so that epitopes are available for any downstream application.
The REAlease CD279 MicroBead Kit has been developed for the isolation of CD279+ cells from PBMCs. The REAlease CD279 MicroBead Kit is an indirect magnetic labelling system that allows to obtain cells free of MicroBeads and REAlease Biotin Complex.
CD279, also known as PD-1 (programmed cell death 1), is expressed on T cells, B cells, NK cells, activated myeloid cells, and dendritic cells are labeled with REAlease CD279-Biotin (REAlease Biotin Complex). Subsequently, REAlease Anti-Biotin MicroBeads (CD279, human) bind to the REAlease Biotin Complex. Then, the cell suspension is loaded onto a MACS Column, which is placed in the magnetic field of a MACS Separator. The magnetically labeled cells are retained within the column. The unlabeled non-target cells flow through; this cell fraction is thus depleted of CD279+ cells.
Isolation of CD279+ label free cells. The selected CD279+ cells can be sorted according to a second marker of interest, for example, CD8, CD4, CD137 (4-1BB), CD223 (LAG-3), or CD366 (TIM-3).
MS or LS Columns.
CD279+ cells were isolated from human PBMC using the REAlease CD279 MicroBead Kit, MS Columns, and a MiniMACS™ Separator. Cells were fluorescently stained with CD279-PE and CD3-VioBlue and analyzed by flow cytometry using the MACSQuant Analyzer X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence.
Label-free cells - release of REAlease Biotin Complex: The efficient removal of all labels was shown by using Biotin Antibody-APC to analyze the cells by flow cytometry for the presence of REAlease Biotin Complex. Directly after isolation, the cells showed staining of biotin (“MicroBead-free CD279+ cells”), whereas the label-free CD279+ cells after the REAlease Biotin Complex release were negative for biotin similar to the non-labeled cells before separation.